Literature DB >> 2320705

Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats.

J U Adams1, S G Holtzman.   

Abstract

Food-deprived rats were trained to lever-press on a fixed interval 3-min schedule of food presentation. Using a cumulative dosing procedure, morphine and naltrexone were tested weekly for effects on rates of responding. A separate group of subjects was tested weekly for morphine analgesia using the tail-flick assay. Chronic morphine infusion (10 mg/kg/day, SC, from a 4-week osmotic pump) induced tolerance to the rate-decreasing and analgesic effects of morphine as demonstrated by a more than 4-fold increase in the morphine ED50s for both of these effects, relative to those of predependent rats. Physical dependence was evidenced in the operant procedure by increased sensitivity to the rate-decreasing effects of the opioid antagonist, naltrexone, such that the ED50 for naltrexone was 5000 times lower than it was in predependent animals. In addition, marked weight loss was observed over the 2-h naltrexone test session. The degree of tolerance was a function of both the length of chronic administration and of the maintenance dose and was of a similar magnitude for operant responding and analgesia. Further, the degree of tolerance and dependence was comparable to that observed in other studies that used different methods of chronic drug administration. Thus, osmotic pumps provide a convenient and effective alternative for chronic drug administration in behavioral studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320705     DOI: 10.1007/bf02243995

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Discriminative stimulus properties of fentanyl and morphine: tolerance and dependence.

Authors:  F C Colpaert; J J Kuyps; C J Niemegeers; P A Janssen
Journal:  Pharmacol Biochem Behav       Date:  1976-10       Impact factor: 3.533

2.  Oral ingestion of narcotic analgesics by rats.

Authors:  D E McMillan; J D Leander; T W Wilson; S C Wallace; T Fix; S Redding; R T Turk
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

3.  Operant behavior in the morphine-dependent rhesus monkey.

Authors:  S G Holtzman; J E Villarreal
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

4.  The addiction cycle to narcotics in the rat and its relation to catecholamines.

Authors:  T Akera; T M Brody
Journal:  Biochem Pharmacol       Date:  1968-05       Impact factor: 5.858

5.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

6.  Effects of naloxone on schedule-controlled behavior in morphine-maintained pigeons.

Authors:  A M Young; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1978-04       Impact factor: 4.030

7.  Tolerance to antinociceptive effects of morphine without tolerance to its effects on schedule-controlled behavior.

Authors:  R E Solomon; E A Wasserman; G F Gebhart
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  The development of tolerance to morphine in the rat.

Authors:  M Fernandes; S Kluwe; H Coper
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

9.  Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons.

Authors:  C P France; J U Adams; J H Woods
Journal:  Neuropharmacology       Date:  1987-06       Impact factor: 5.250

10.  Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.

Authors:  V F Gellert; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

View more
  14 in total

1.  The effects of acute and chronic steady state methadone on memory retrieval in rats.

Authors:  Erin Cummins; Craig P Allen; Alexander Ricchetti; Emily Boughner; Kayla Christenson; Megan Haines; Cheryl L Limebeer; Linda A Parker; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2012-01-19       Impact factor: 4.530

2.  Effects of the imidazoline I2 receptor agonist 2-BFI on the development of tolerance to and behavioural/physical dependence on morphine in rats.

Authors:  David A Thorn; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

Review 3.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

4.  Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.

Authors:  M J Picker; J Yarbrough
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.

Authors:  Carol A Paronis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2010-11-04       Impact factor: 4.030

6.  Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps.

Authors:  C Cohen; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

7.  Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.

Authors:  Linda A Dykstra; Bradford D Fischer; Rebecca E Balter; Fredrick E Henry; Karl T Schmidt; Laurence L Miller
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

8.  Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.

Authors:  F Noble; B M Cox
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.

Authors:  David A White; Michael E Ballard; Alvin C Harmon; Stephen G Holtzman
Journal:  Brain Res Bull       Date:  2008-05-09       Impact factor: 4.077

10.  Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.

Authors:  Caren L Steinmiller; Alice M Young
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.